Company Profile
Precipio Diagnostics Stock Price, News & Catalysts
- Ticker:
- PRPO
- Exchange:
- NASDAQ
- Sector:
- MedTech
- Location:
- United States
Stock performance
23.90 USD (+1.70%)
Close
Last updated: August 17, 2026
40.2M USD
Market cap
Why the stock is moving
The latest company update was “Precipio Announces Q2-2026 Financial Results”. PRPO changed 1.70% and closed at $23.90 on Aug 17, 2026, indicating a relatively limited closing-price reaction to this earnings update.
Company overview
Cancer Diagnostics Company
Precipio is a specialty cancer diagnostics company focused on reducing misdiagnosis in hematologic malignancies. It develops testing approaches intended to improve diagnostic accuracy for physicians, laboratories, and patients.
Integrated Clinical Laboratory
The company operates its own clinical laboratory, where it develops, validates, and uses diagnostic technologies in routine patient testing. This internal laboratory infrastructure provides a setting for generating clinical evidence and refining new assays before broader commercialization.
Products and Services Model
Precipio combines laboratory testing services with proprietary diagnostic products marketed to laboratories. This model allows the company to serve physicians directly while also distributing technologies that other laboratories can incorporate into their workflows.
Future catalysts
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Precipio Diagnostics (PRPO)?
Precipio Diagnostics (PRPO) most recently closed at 23.90 USD, a +1.70% move versus the previous session.
What is the market cap of Precipio Diagnostics (PRPO)?
Precipio Diagnostics currently has a market capitalization of 40.2M USD on BioPharmSignal.
What does Precipio Diagnostics do?
Cancer Diagnostics Company Precipio is a specialty cancer diagnostics company focused on reducing misdiagnosis in hematologic malignancies. It develops testing approaches intended to improve diagnostic accuracy for physicians, laboratories, and patients. Integrated Clinical Laboratory The company operates its own clinical laboratory, where it develops,...
On which exchange is PRPO stock listed?
Precipio Diagnostics (PRPO) is associated with NASDAQ, United States, MedTech.
What is Cancer?
Cancer Diagnostics Company Precipio is a specialty cancer diagnostics company focused on reducing misdiagnosis in hematologic malignancies.
Which conditions is Precipio Diagnostics targeting with Cancer?
Precipio Diagnostics is associated with cancer therapeutics based on its company overview and current catalyst commentary.
What is Diagnostics?
Cancer Diagnostics Company Precipio is a specialty cancer diagnostics company focused on reducing misdiagnosis in hematologic malignancies.
What is Precipio?
Cancer Diagnostics Company Precipio is a specialty cancer diagnostics company focused on reducing misdiagnosis in hematologic malignancies.